In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Anifed, Afeditab CR, Nifediac, Nifedical, Procardia, Nifedipine Drug Master File in Korea (Anifed, Afeditab CR, Nifediac, Nifedical, Procardia, Nifedipine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Anifed, Afeditab CR, Nifediac, Nifedical, Procardia, Nifedipine. The MFDS reviews the Anifed, Afeditab CR, Nifediac, Nifedical, Procardia, Nifedipine KDMF as part of the drug registration process and uses the information provided in the Anifed, Afeditab CR, Nifediac, Nifedical, Procardia, Nifedipine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Anifed, Afeditab CR, Nifediac, Nifedical, Procardia, Nifedipine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Anifed, Afeditab CR, Nifediac, Nifedical, Procardia, Nifedipine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Anifed, Afeditab CR, Nifediac, Nifedical, Procardia, Nifedipine suppliers with KDMF on PharmaCompass.